New York: The vaccination against Ebola of high-risk populations began on Monday in Côte d’Ivoire following the discovery of an outbreak in the country three days ago. The swift response came after vaccines manufactured by Merck, which the World Health Organization (WHO) helped to secure to fight a four-month long outbreak in neighbouring Guinea, were quickly sent to the country. more